Renal effects of gentamicin in chronic bile duct ligated rats

Digestive Diseases and Sciences

Volumn 51, Issue 2, 2006, Pages 406-415

  Ackerman, Zvi ^a   Karmeli, Fanny ^a   Pizov, Galina ^a   Ben Dov, Iddo ^a   Pappo, Orit ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bile duct ligation; Cirrhosis; Gentamicin; Nephrotoxicity; Plasma nitrites; Prostaglandin E2

Indexed keywords

CREATININE; GENTAMICIN; NITRIC OXIDE; PROSTAGLANDIN E2; SODIUM;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG MEGADOSE; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY MEDULLA; LIVER CIRRHOSIS; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; RENAL PROTECTION; SHAM FEEDING; SODIUM EXCRETION;

ANIMALS; ANTI-BACTERIAL AGENTS; BILE DUCTS; CHOLESTASIS; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENTAMICINS; KIDNEY; LIGATION; LIVER DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33644905296     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-3145-8     Document Type: Article

References (50)

1. Caly WR, Strauss E: A prospective study on bacterial infections in patients with cirrhosis. J Hepatol 18:353-358, 1993
2. Schentag JJ, Plaut ME, Cerra FB, Wels PB, Walczak P, Buckley RJ: Aminoglycoside nephrotoxicity in critically ill surgical patients. J Surg Res 26:270-279, 1979
3. Smith CR, Lipsky JJ, Laskin OL, et al.: Double blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 302:1106-1109, 1980
4. Moore RD, Smith CR. Lipsky JJ, Mellits ED, Lietman PS: Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 100:352-357, 1984
5. Moore RD, Smith CR, Lietman PS: Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides. Am J Med 80:1093-1097, 1986
6. Cabrera J, Arroyo V, Ballesta AM, et al.: Aminoglycoside nephrotoxicity in cirrhosis. Gastroenterology 82:97-105, 1982
7. Felisart J, Rimola A, Arroyo V, et al.: Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 5:457-462, 1985
8. Desai TK, Tsang TK: Aminoglycoside nephrotoxicity in obstructive jaundice. Am J Med 85:47-50, 1988
9. Lucena MI, Andrade RJ, Cabella MR, Hidalgo R, Gonzalez-Correa JA, Sanchez de la Cuesta F: Aminoglycoside associated nephrotoxicity in extrahepatic obstructive jaundice. J Hepatol 22:189-196, 1995
10. McCormick PA, Greenslade L, Kibbler CC, Chin JKT, Burroughs AK, McIntyre N: A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients. Hepatology 25:833-836, 1997
11. Camps J, Sola X, Rimola A, et al.: Comparative study of aminoglycoside nephrotoxicity in normal rats and rats with experimental cirrhosis. Hepatology 8:837-844, 1988
12. Zager RA: A focus of tissue necrosis increases renal susceptibility to gentamicin administration. Kidney Int 33:84-90, 1988
13. Vakil N, Abu-Alfa A, Mujais SK: Gentamicin nephrotoxicity in extrahepatic cholestasis. Modulation by dietary calcium. Hepatology 9:519-524, 1989
14. Lucena MI, Gonzalez-Correa JA, Andrade RJ, Ibanez J, Torres D, Sanchez de la Cuesta F: Enhanced gentamicin nephrotoxicity after experimental biliary obstruction in rats. Pharmacol Toxicol 65:352-356, 1989
15. Vakil NB, Gutkowska J, Abu-Alfa A, Mujais S: Effects of acute and chronic bile duct ligation on plasma atrial natriuretic factor in the rat (abstract). Am J Hypertens 1:135A, 1988
16. Koepke JP, Jones S, DiBona GF: Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Am J Physiol 252:R1019-R1023, 1987
17. Ackerman Z, Karmeli F, Amir G, Rachmilewitz D: Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats. J Hepatol 24:478-486, 1996
18. Quarum ML, Houghton DC, Gilbert DN, McCarron DA, Bennett WM: Increasing dietary calcium moderates experimental gentamicin nephrotoxicity. J Lab Clin Med 103:104-114, 1984
19. Sruehr DJ, Marletta MA: Mammalian nitrite biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 82:7738-7742, 1985
20. Bennett WM: Aminoglycoside nephrotoxicity. Nephron 35:73-77, 1983
21. Glyselynck AM, Forrey A, Cutler R: Pharmacokinetics of gentamicin: Distribution and plasma and renal clearance. J Infect D 124:S70-S76, 1971
22. Sundin DP, Sandoval R, Molitoris BA: Gentamicin inhibits renal protein and phospholipid metabolism in rats: Implications involving intracellular trafficking. J Am Soc Nephrol 12:114-123, 2001
23. Laurent G, Kishore BK, Tulkens PM: Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol 40:2383-2392, 1990
24. Lipsky JJ, Lietman PS: Aminoglycoside inhibition of renal phosphatidylinosotol phospholipase C. J Pharmacol Exp Ther 220:287-292, 1982
25. Assael BM, Chiabrando C, Gagliardi L, Noseda A, Bamonte F, Salmona ML: Prostaglandins and aminoglycoside nephrotoxicity. Toxicol Appl Pharmacol 78:386-394, 1985
26. Vesce F, Pavan B, Buzzi M, et al.: Effect of different classes of antibiotics on amniotic prostaglandin E release. Prostaglandins Other Lipid Mediat 57:207-218, 1999
27. Piret J, Kishore BK, Tulkens PM: Effect of substrate organization on the activity and on the mechanisms of gentamicin-induced inhibition of rat liver lysosomal phospholipase A-1. Biochem Pharmacol 43:895-898, 1992
28. Zager RA, Sharma HM, Johannes GA: Gentamicin increases renal susceptibility to an acute ischemic insult. J Lab Clin Med 101:670-678, 1983
29. Wiest R, Shah V, Sessa WC, Groszmann RJ: NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 276:G1043-G1051, 1999
30. Niederberger M, Gines P, Martin PY, et al.: Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 24:947-951, 1996
31. Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann J: Increased endothelial nitric oxide synthase activity in hyperemic vessels of portal hypertensive rats. J Hepatol 25:370-378, 1996
32. Morales-Ruiz M, Jimenez W, Perez-Sala D, et al.: Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 24:1481-1486, 1996
33. Gadano AC, Songi P, Heller J, Moreau R, Bories PN, Lebrec D: Vascular nitric oxide production during the development of two experimental models of portal hypertension. J Hepatol 30:896-903, 1999
34. Bech JN, Nielsen CB, Pedersen EB: Effects of systemic nitric oxide synthesis inhibition on renal plasma flow, glomerular filtration rate, urinary sodium excretion and vasoactive hormones in healthy humans. Am J Physiol 270:F845-F851, 1996
35. Lumsden AB, Henderson MJ, Kutner MH: Endotoxin levels measured by chromogenic assay in portal hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8:232-236, 1988
36. Tilz H, Wilmer A, Vogel W, et al.: Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274, 1992
37. Wilkinson SP, Moodie H, Stamatakis JD, Kakkar VV, Williams R: Endotoxemia and renal failure in cirrhosis and obstructive jaundice. Br Med J 2:1415-1418, 1976
38. Kocsar LT, Bertok L, Vartereresz V: Effect of bile acids on the intestinal absorption of endotoxin in rats. J Bacteriol 100:220-223, 1969
39. Stark ME, Szurszewski JH: Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 103:1928-1949, 1992
40. Navasa M, Follo A, Fillella X, et al.: Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality. Hepatology 27:1227-1232, 1998
41. Zager RA, Prior RB: Gentamicin and gram negative bacteremia. A synergism for the development of experimental nephrotoxic acute renal failure. J Clin Invest 78:196-204, 1986
42. Coopersmith CM, Amiot DM 2nd, Stomberg PE, et al.: Antibiotics improve survival and alter the inflammatory profile in murine model of sepsis from Pseudomonas aeruginosa pneumonia. Shock 19:408-411, 2003
43. Tsumura H, Hiyama E, Kodama T, Sueda T, Yokoyama T: Relevance of antimicrobial agent-induced endotoxin release from in vitro cultured Escherichia coli and in vivo experimental infection with Gram-negative bacilli. Int J Antimicrob Agents 21:463-470, 2003
44. Rivas-Cabanero L, Rodriguez-Barbero A, Arevalo M, Lopez-Novoa JM: Effect of NG-nitro-arginine methyl ester on nephrotoxicity induced by gentamicin in rats. Nephron 71:203-207, 1995
45. Zetterstrom R, Ernster L: Bilirubin, an uncoupler of oxidative phosphorylation in isolated mitochondria. Nature 178:1335-1337, 1956
46. Parkinson TM, Olson JA: Inhibitory effects of bile acids on adenosine triphosphate, oxygen consumption and the transport and diffusion of water soluble substances in the small intestine of the rat. Life Sci 3:107-112, 1964
47. Weissman G: Studies of lysosomes. VI. The effects of natural steroids and bile acids on lysosomes in vitro. Biochem Pharmacol 14:525-535, 1965
48. Humes HD: Aminoglycoside nephrotoxicity. Kidney Int 33:900-911, 1988
49. Leung N, Croatt AJ, Haggard JJ, Grande JP, Nath KA: Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat. Kidney Int 60:1047-1057, 2001
50. Agarwal A, Balla J, Alam J, Croatt AJ, Nath KA: Induction of heme oxygenase in toxic renal injury: A protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48:1298-1307, 1995